Lorenzo Tozzi
About Lorenzo Tozzi
Lorenzo Tozzi is a Principal Scientist at Tessera Therapeutics in Somerville, Massachusetts, where he has worked since 2022. He has a strong background in biotechnology and molecular biology, with previous roles at bluebird bio and Tufts University.
Work at Tessera Therapeutics
Lorenzo Tozzi has been serving as a Principal Scientist at Tessera Therapeutics since 2022. In this role, he contributes to the company's mission of advancing genetic medicine through innovative technologies. Tessera Therapeutics is located in Somerville, Massachusetts, where Tozzi applies his expertise in biotechnology and molecular biology to drive research and development initiatives.
Previous Experience at bluebird bio
Before joining Tessera Therapeutics, Lorenzo Tozzi worked at bluebird bio as a Scientist II from 2018 to 2022. His tenure at the company lasted four years and took place in Cambridge, Massachusetts. During this time, he focused on developing gene therapies and contributed to various projects aimed at treating genetic diseases.
Academic Background and Postdoctoral Work
Lorenzo Tozzi completed his postdoctoral fellowship at Tufts University from 2013 to 2018, where he engaged in advanced research in biotechnology. Prior to this, he held a postdoctoral position at Università degli Studi di Firenze for 11 months in 2013. His academic journey also includes a Doctor of Philosophy (PhD) in Molecular Biology from the same university, which he earned from 2009 to 2012.
Education in Biotechnology and Molecular Biology
Tozzi holds a Master’s degree in Medical Biotechnology from Università degli Studi di Firenze, completed between 2006 and 2008. He also obtained a Bachelor’s degree in Biotechnology from the same institution, which he completed from 2003 to 2006. His educational background is complemented by a PhD in Molecular Biology, enhancing his expertise in the field.
Visiting Scientist Experience
In 2011, Lorenzo Tozzi served as a Visiting Scientist at CeMM in Austria for a total of five months, split into two separate periods. This experience allowed him to collaborate with international researchers and expand his knowledge in molecular biology and biotechnology.